143 related articles for article (PubMed ID: 33559534)
1. Analysis of blood clotting with the total thrombus analysis system in healthy dogs.
Iwanaga T; Fukushima R; Nagasato T; Maruyama I; Miura N
J Vet Diagn Invest; 2021 Mar; 33(2):357-361. PubMed ID: 33559534
[TBL] [Abstract][Full Text] [Related]
2. A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis.
Iwanaga T; Miura N; Brainard BM; Brooks MB; Goggs R
Front Vet Sci; 2020; 7():307. PubMed ID: 32582782
[TBL] [Abstract][Full Text] [Related]
3. Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.
Yamaguchi Y; Moriki T; Igari A; Matsubara Y; Ohnishi T; Hosokawa K; Murata M
Thromb Res; 2013 Aug; 132(2):263-70. PubMed ID: 23777751
[TBL] [Abstract][Full Text] [Related]
4. Viscoelastic pharmacodynamics after dalteparin administration to healthy dogs.
Brainard BM; Koenig A; Babski DM; Blong AE; Scherk JR
Am J Vet Res; 2012 Oct; 73(10):1577-82. PubMed ID: 23013183
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Total Thrombus-Formation System (T-TAS): application to human and mouse blood analysis.
Al Ghaithi R; Mori J; Nagy Z; Maclachlan A; Hardy L; Philippou H; Hethershaw E; Morgan NV; Senis YA; Harrison P
Platelets; 2019; 30(7):893-900. PubMed ID: 30365350
[TBL] [Abstract][Full Text] [Related]
6. Microfluidics contrasted to thrombelastography: perplexities in defining hypercoagulability.
Lawson PJ; Moore HB; Moore EE; Gerich ME; Stettler GR; Banerjee A; Schulick RD; Nydam TL
J Surg Res; 2018 Nov; 231():54-61. PubMed ID: 30278969
[TBL] [Abstract][Full Text] [Related]
7. Comparison of chronological changes in blood characteristics in the atrium and peripheral vessels after the development of non-valvular atrial fibrillation.
Yamada S; Hirao D; Miura N; Iwanaga T; Kawaguchi T; Yoshimura A; Oomori T; Nagasato T; Maruyama I; Fukushima R
Thromb Res; 2018 Nov; 171():31-37. PubMed ID: 30245238
[TBL] [Abstract][Full Text] [Related]
8. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time.
Jessen LR; Wiinberg B; Jensen AL; Kjelgaard-Hansen M; Jensen KH; Pedersen LB; Kristensen AT
Vet Clin Pathol; 2008 Dec; 37(4):363-72. PubMed ID: 19055570
[TBL] [Abstract][Full Text] [Related]
9. Effect of dalteparin administration on thrombin generation kinetics in healthy dogs.
Gara-Boivin C; de Castillo JRE; Dunn ME; Bédard C
Vet Clin Pathol; 2017 Jun; 46(2):269-277. PubMed ID: 28430367
[TBL] [Abstract][Full Text] [Related]
10. Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
Ito M; Kaikita K; Sueta D; Ishii M; Oimatsu Y; Arima Y; Iwashita S; Takahashi A; Hoshiyama T; Kanazawa H; Sakamoto K; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Hokimoto S; Yamabe H; Ogawa H
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811167
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antithrombotic abilities of non-vitamin K antagonist oral anticoagulants using the Total Thrombus-formation Analysis System
Idemoto Y; Miura SI; Norimatsu K; Suematsu Y; Hitaka Y; Shiga Y; Morii J; Imaizumi S; Kuwano T; Iwata A; Zhang B; Ogawa M; Saku K
Heart Vessels; 2017 Mar; 32(3):309-316. PubMed ID: 27325226
[TBL] [Abstract][Full Text] [Related]
12. Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease.
Kaikita K; Hosokawa K; Dahlen JR; Tsujita K
Thromb Haemost; 2019 Oct; 119(10):1554-1562. PubMed ID: 31330558
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of dalteparin on thrombin generation in canine plasma.
Gara-Boivin C; Del Castillo JRE; Dunn ME; Bédard C
Vet Clin Pathol; 2017 Sep; 46(3):442-450. PubMed ID: 28605123
[TBL] [Abstract][Full Text] [Related]
14. Effects of low molecular weight heparin on clot rate and activated clotting time: an in vitro study.
Shi XB; Bai Y; Li J; Xiao J; Wang JQ; Zheng H
Chin Med J (Engl); 2013; 126(18):3553-6. PubMed ID: 24034107
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
Ågren A; Holmström M; Schmidt DE; Hosokawa K; Blombäck M; Hjemdahl P
Thromb Haemost; 2017 Jan; 117(1):75-85. PubMed ID: 27761577
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia and the anticoagulants dalteparin and acetylsalicylic acid affect human placental amino acid transport.
Kleppa MJ; Erlenwein SV; Darashchonak N; von Kaisenberg CS; von Versen-Höynck F
PLoS One; 2014; 9(6):e99217. PubMed ID: 24901243
[TBL] [Abstract][Full Text] [Related]
17. Use of microfluidics to assess the platelet-based control of coagulation.
Nagy M; Heemskerk JWM; Swieringa F
Platelets; 2017 Jul; 28(5):441-448. PubMed ID: 28358995
[TBL] [Abstract][Full Text] [Related]
18. Contact activation of blood coagulation on a defined kaolin/collagen surface in a microfluidic assay.
Zhu S; Diamond SL
Thromb Res; 2014 Dec; 134(6):1335-43. PubMed ID: 25303860
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic thrombosis under multiple shear rates and antiplatelet therapy doses.
Li M; Hotaling NA; Ku DN; Forest CR
PLoS One; 2014; 9(1):e82493. PubMed ID: 24404131
[TBL] [Abstract][Full Text] [Related]
20. A method for measuring capillary bleeding time in non-anaesthetized dogs: prolongation of the bleeding time by acetylsalicylic acid.
Nolte I; Niemann C; Bowry SK; Failing K; Müller-Berghaus G
Zentralbl Veterinarmed A; 1997 Dec; 44(9-10):625-8. PubMed ID: 9465783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
